These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 3348466)

  • 41. First-incidence of DSM-IV mood, anxiety and substance use disorders and its determinants: results from the Netherlands Mental Health Survey and Incidence Study-2.
    de Graaf R; ten Have M; Tuithof M; van Dorsselaer S
    J Affect Disord; 2013 Jul; 149(1-3):100-7. PubMed ID: 23399481
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Classification of mood disorders in DSM-V and DSM-VI.
    Joyce PR
    Aust N Z J Psychiatry; 2008 Oct; 42(10):851-62. PubMed ID: 18777229
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevalence of mood, anxiety, and substance-abuse disorders for older Americans in the national comorbidity survey-replication.
    Gum AM; King-Kallimanis B; Kohn R
    Am J Geriatr Psychiatry; 2009 Sep; 17(9):769-81. PubMed ID: 19700949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can drug-induced depressions be identified by their clinical features?
    Patten SB; Lamarre CJ
    Can J Psychiatry; 1992 Apr; 37(3):213-5. PubMed ID: 1350503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
    de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
    J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The concept of mood disorder in ICD-10].
    Nakane H; Nakane Y
    Nihon Rinsho; 2001 Aug; 59(8):1477-83. PubMed ID: 11519145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rates of DSM-IV psychiatric disorders among adolescents in a large metropolitan area.
    Roberts RE; Roberts CR; Xing Y
    J Psychiatr Res; 2007 Dec; 41(11):959-67. PubMed ID: 17107689
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence and comorbidity of DSM-III-R diagnoses in a birth cohort of 15 year olds.
    Fergusson DM; Horwood LJ; Lynskey MT
    J Am Acad Child Adolesc Psychiatry; 1993 Nov; 32(6):1127-34. PubMed ID: 8282656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reliability and validity of the Coolidge Axis II Inventory: a new inventory for the assessment of personality disorders.
    Coolidge FL; Merwin MM
    J Pers Assess; 1992 Oct; 59(2):223-38. PubMed ID: 1432558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DSM-III-R classification of murderous youth: help or hindrance?
    Myers WC; Kemph JP
    J Clin Psychiatry; 1990 Jun; 51(6):239-42. PubMed ID: 2347861
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comorbidity among anxiety disorders: implications for treatment and DSM-IV.
    Brown TA; Barlow DH
    J Consult Clin Psychol; 1992 Dec; 60(6):835-44. PubMed ID: 1460147
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anxiety, depression, psychotropic drug use and cognitive impairment.
    Paterniti S; Dufouil C; Bisserbe JC; Alpérovitch A
    Psychol Med; 1999 Mar; 29(2):421-8. PubMed ID: 10218933
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Organic depression associated with flunarizine.
    Patten S; Thompson J
    Can J Psychiatry; 1995 Mar; 40(2):111-2. PubMed ID: 7788616
    [No Abstract]   [Full Text] [Related]  

  • 54. Epidemiological associations between gambling behavior, substance use & mood and anxiety disorders.
    el-Guebaly N; Patten SB; Currie S; Williams JV; Beck CA; Maxwell CJ; Wang JL
    J Gambl Stud; 2006; 22(3):275-87. PubMed ID: 17009123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Japanese psychology students as psychiatric diagnosticians: application of criteria of mood and anxiety disorders to written case vignettes using the RDC and DSM-IV.
    Sugiura T; Hasui C; Aoki Y; Sugawara M; Tanaka E; Sakamoto S; Kitamura T
    Psychol Rep; 1998 Jun; 82(3 Pt 1):771-81. PubMed ID: 9676489
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychopathology in hospitalized alcoholics.
    Hesselbrock MN; Meyer RE; Keener JJ
    Arch Gen Psychiatry; 1985 Nov; 42(11):1050-5. PubMed ID: 4051682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
    Brady KT; Verduin ML
    Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Smit F; Vollebergh WA; Spijker J
    Am J Psychiatry; 2002 Apr; 159(4):620-9. PubMed ID: 11925301
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DSM depression and anxiety criteria and severity of symptoms in primary care: cross sectional study.
    Nease DE; Aikens JE
    BMJ; 2003 Nov; 327(7422):1030-1. PubMed ID: 14593040
    [No Abstract]   [Full Text] [Related]  

  • 60. Substance use disorders increase the odds of subsequent mood disorders.
    Kenneson A; Funderburk JS; Maisto SA
    Drug Alcohol Depend; 2013 Dec; 133(2):338-43. PubMed ID: 23906994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.